1. Home
  2. MDAI vs HCWB Comparison

MDAI vs HCWB Comparison

Compare MDAI & HCWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

MDAI

Spectral AI Inc.

HOLD

Current Price

$1.61

Market Cap

50.5M

Sector

Health Care

ML Signal

HOLD

Logo HCW Biologics Inc.

HCWB

HCW Biologics Inc.

HOLD

Current Price

$2.47

Market Cap

5.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MDAI
HCWB
Founded
2013
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
50.5M
5.0M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
MDAI
HCWB
Price
$1.61
$2.47
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$3.00
$35.00
AVG Volume (30 Days)
134.3K
160.3K
Earning Date
05-12-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
65.88
N/A
EPS
N/A
N/A
Revenue
$19,650,000.00
$4,099,750.00
Revenue This Year
N/A
N/A
Revenue Next Year
$23.50
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.18
$0.25
52 Week High
$2.97
$6.11

Technical Indicators

Market Signals
Indicator
MDAI
HCWB
Relative Strength Index (RSI) 49.78 40.66
Support Level $1.50 $2.35
Resistance Level $1.77 $4.12
Average True Range (ATR) 0.06 0.40
MACD 0.00 -0.00
Stochastic Oscillator 56.04 17.62

Price Performance

Historical Comparison
MDAI
HCWB

About MDAI Spectral AI Inc.

Spectral AI Inc is an AI company focused on predictive medical diagnostics. Its DeepView System uses proprietary AI algorithms to distinguish between fully damaged, partially damaged and healthy human tissue characters invisible to the naked eye, at the initial time point of wound presentation. The DeepView System delivers a binary prediction on the wound's capacity to heal or not-heal by a specified time point in the future. The company focuses on the burn indication which is supported by the BARDA PBS contract.

About HCWB HCW Biologics Inc.

HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.

Share on Social Networks: